Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tomotherapy with Cisplatin and Docetaxel in Stage III NSCLC
NCT00379717Phase 2Unknown
- Sponsor
- AstraZeneca
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cisplatin, docetaxel in non-small cell lung cancer (NSCLC), sponsored by AstraZeneca. Status: unknown.
02
Drugs
cisplatindocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00379717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379717.